SpyGlass Pharma closes IPO, raises $172.5M at $16.00/share

SpyGlass Pharma, Inc.

Closed IPO of 10,781,250 shares (incl. full exercise of underwriters' option for 1.4M additional shares) at $16.00/share.
Aggregate gross proceeds of $172.5 million before underwriting discounts and offering expenses.
Common stock began trading on Nasdaq Global Select Market under ticker SGP on February 6, 2026.
Habib Dable appointed to board as Class I director and to compensation committee; receives standard director compensation and option grant.

item 5.02 item 5.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SpyGlass Pharma, Inc.: Adopted amended and restated bylaws effective as of the same date (effective 2026-02-09).

Change: bylaw amendment
Effective: 2026-02-09

Exact text from the filing

Effective as of February 9, 2026, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the completion of the IPO.

View on SEC.gov

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

SpyGlass Pharma, Inc.: Filed amended and restated certificate of incorporation in connection with IPO completion (effective 2026-02-09).

Change: charter amendment
Effective: 2026-02-09

Exact text from the filing

On February 9, 2026, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware in connection with the completion of the IPO.

View on SEC.gov

29 governance changes filed in the last 30 days. Browse all governance changes →

SpyGlass Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-006460

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.